TNF and inflammatory bowel disease: This absence of signals in IBD is further supported by real-world comparative data from a large U.S. claims cohort of biologic-naïve psoriasis patients, in which the rate of new-onset AF was essentially identical between those receiving ustekinumab and those on TNF-α inhibitors [49].